Posted On: 08/20/2014 5:04:43 PM
Post# of 30035
Re: gobears1985 #4414
Exactly! Giving revenue guidance on Sept. 2nd would be unwise, or poor planning, unless they had completed the "bridge study" and had positive data to report to us. Positive data and revenue guidance go hand in hand.
The partnership will come after the CC but before the Shareholder meeting.
My vote on the authorized shares, if it matters, is dependent on AMBS hitting these 3 LymPro milestones in a respectable manner. If they do, they have my vote on the authorized shares.
The partnership will come after the CC but before the Shareholder meeting.
My vote on the authorized shares, if it matters, is dependent on AMBS hitting these 3 LymPro milestones in a respectable manner. If they do, they have my vote on the authorized shares.
(0)
(0)Scroll down for more posts ▼
